TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Obagi Medical Products, Inc. (NASDAQ:OMPI) Investor Files Lawsuit Against Takeover Attempt By Valeant Pharmaceuticals

  • If you purchased shares of Obagi Medical Products, Inc. (NASDAQ:OMPI) prior to March 20, 2013, and currently hold any of those NASDAQ:OMPI shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

Mar. 25, 2013 (Shareholders Foundation) - An investor in shares of Obagi Medical Products, Inc. (NASDAQ:OMPI) filed a lawsuit to halt the takeover of Obagi Medical Products, Inc. by Valeant Pharmaceuticals International at $19.75 per NASDAQ:OMPI share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:OMPI stockholders by agreeing to sell the co...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: